| COVID-19 severity | COVID-19 mortality | ||||||
---|---|---|---|---|---|---|---|---|
Univariate | #Multivariate | Univariate | #Multivariate | |||||
OR (95% C. I) | P value | OR (95% C. I) | P value | OR (95% C. I) | P value | OR (95% C. I) | P value | |
Male | 0.39 (0.17–0.86) | 0.02* | 0.73 (0.25–2.17) | 0.5 | 0.5(0.18–1.67) | 0.3 |  |  |
Age | 1.01 (0.97–1.04) | 0.8 |  |  | 1.17 )1.08–1.28) | < 0.001* | 1.18 (1.04–1.34) | 0.01* |
Low vitamin D | 2.61 (1.16–6.18) | 0.023* | 3.61 (1.37–10.4) | 0.01* | 0.64 (0.41–0.99) | 0.045* |  |  |
High NLR | 2.25 (1.01–5.08) | 0.041* | 1.19 (0.38–3.59) | 0.8 | 1.05 (0.99–1.11) | 0.08 |  |  |
High CRP | 7.69 (3.06–22.3) | < 0.001* | 5.80 (1.60–22.8) | 0.009* | 1.01 (1.0-1.02) | 0.04* |  |  |
High D-dimer | 4.51 (1.98–10.7) | < 0.001* | 1.05 (0.27–4.12) | > 0.9 | 1 (1-1.01) | 0.7 |  |  |
High ferritin | 2.75 (1.20–6.33) | 0.017* | 1.59 (0.54–4.71) | 0.3 | 1 (1.00-1.1) | 0.6 |  |  |
High LDH | 4.55 (1.62–16.3) | 0.008* | 2.98 (0.83–13.2) | 0.12 | 1 (0.99- 1) | 0.3 |  |  |
Genotype (rs4588) | Â | Â | Â | Â | Â | Â | Â | Â |
 CC (reference) |  |  |  |  |  |  |  |  |
 AA | 0.00 (00–00) | >0.9 |  |  | 0.00 (00–00) | 0.9 |  |  |
 CA | 1.08(0.44–2.54) | >0.9 |  |  | 1.08(0.44–2.54) | 0.9 |  |  |
Genotype (rs7041) | Â | Â | Â | Â | Â | Â | Â | Â |
 TT (reference) |  |  |  |  |  |  |  |  |
 GG | 1.65(0.50–6.5) | 0.4 |  |  | 1.65(0.50–6.52) | 0.4 |  |  |
 TG | 1.60(0.49–6.2) | 0.5 |  |  | 1.60(0.49–6.24) | 0.5 |  |  |
Severity |  |  |  |  | 4.61 (1.23–19.1) | 0.025* | 5.78(1.12–29.7) | 0.03* |
Diabetes |  |  |  |  | 1.78 (0.58–5.42) | 0.3 |  |  |
Hypertension |  |  |  |  | 2.2 (0.71–6.62) | 0.175 |  |  |
IHD | Â | Â | Â | Â | 0 | 0.9 | Â | Â |
CKD |  |  |  |  | 8 (1.93–33.1) | 0.004* | 0.827(0.08–8.4) | 0.8 |
Chronic liver D |  |  |  |  | 1.5 (0.32–7.93) | 0.57 |  |  |
Medications | Â | Â | Â | Â | Â | Â | Â | Â |
 Corticosteroids |  |  |  |  | 0.34(0.07–2.49) | 0.21 |  |  |
 Remdesivir |  |  |  |  | 0.28(0.06–1.32) | 0.12 |  |  |
 Actemra |  |  |  |  | 0 | > 0.9 |  |  |
 Anticoagulant |  |  |  |  | NA | 0.9 |  |  |